Medical News

RSS

New Technology Showcase highlighting life science technologies to be featured

LifeScience Alley announced today that eight life science organizations from around the United States and Canada will be exhibiting cutting-edge technologies at the association’s Annual Conference on Dec. 9 as part of the New Technology Showcase.

3 Sep 2009

IsoFlow Infusion catheter allows physicians to increase drug concentrations at targeted sites

Vascular Designs, a medical device company, today announced that its IsoFlow(TM) infusion catheter has secured 510(k) marketing clearance by the U.S. Food and Drug Administration (FDA) for the direct delivery of medications into highly targeted areas. An important application of IsoFlow may be in the treatment of cancer.

3 Sep 2009

Tennessee Department Of Health to implement Upp's centralized emergency management solution

Upp Technology will provide a centralized emergency management solution to the Tennessee Department of Health that will improve the availability of patient information and the efficiency of an emergency response. Already utilizing Upp’s irms|Go-Kits, to provide mobile emergency response solutions, Tennessee is now looking to add a centralized server to link the Go-Kits together in the field.

3 Sep 2009

SDA survey participants questioned about their level of concern on H1N1 virus

The good news: Americans recognize that good hygiene is an effective line of defense against the H1N1 virus (previously known as Swine Flu).

3 Sep 2009

Recurrence of Clostridium difficile infection is a growing area of concern in hospitals

Arlington Medical Resources (AMR) and Decision Resources find that relapse or recurrence of infections is the most challenging aspect of treating Clostridium difficile infections in the hospital setting.

3 Sep 2009

ODAC calls for randomized study of Vion's Onrigin injection for treatment of the elderly AML patients

VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VION) today announced the results of the Oncologic Drugs Advisory Committee (ODAC) Meeting at which data for its lead oncology therapeutic Onrigin(TM)(laromustine) Injection were presented for the indication of remission induction treatment for patients sixty years of age or older with de novo poor-risk acute myeloid leukemia (AML).

3 Sep 2009

Nucletron announces financial results for the first half year of 2009

Nucletron, a global leader in radiation oncology, today announced strong financial results over the first half year of 2009. Despite challenging global economic conditions, Nucletron surpassed projections for the first half year.

3 Sep 2009

New probe for identifying chemical process affected proteins functions like GPS

Scientists in Michigan are reporting the development of a powerful new probe for identifying proteins affected by a key chemical process important in aging and disease. The probe works like a GPS or navigation system for finding these proteins in cells. It could lead to new insights into disease processes and identify new targets for disease treatments, the researchers say. Their study is scheduled for the Sept. 18 issue of ACS Chemical Biology, a monthly journal.

3 Sep 2009

Neuronetics raises funds to expand sales team for NeuroStar TMS Therapy

New Leaf Venture Partners (NLV Partners) announced today it has led a $30 million Series D financing round in Neuronetics, Inc., maker of NeuroStar TMS (Transcranial Magnetic Stimulation) Therapy® for the treatment of depression.

3 Sep 2009

First swine-flu vaccine trials reveal strong immune response

Results from the first swine-flu vaccine trials taking place in Leicester reveal a strong immune response after just one dose.

3 Sep 2009

Resident duty-hour reform increases medical complications in teaching hospitals

A new study finds a 2003 reform of the length of resident on-duty hours has led to an increase in the rate of perioperative (the span of all three phases of surgery: before, during and after) complications for patients treated for hip fractures.

3 Sep 2009

New Marketing Authorization Application for Rhucin submitted to the EMEA by Pharming

Biotech company Pharming Group NV ("Pharming" or "the Company") (NYSE Euronext: PHARM) today announced that it has submitted the Marketing Authorization Application (MAA) for Rhucin for the treatment of acute attacks of Hereditary Angioedema (HAE) to the European Medicines Agency (EMEA).

3 Sep 2009

Biogen Idec's MS franchise to present at the 25th Congress of ECTRIMS

Biogen Idec today announced more than 70 platform and poster presentations from the company’s multiple sclerosis (MS) franchise being presented during the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany.

3 Sep 2009

CCEI offers courses that address the needs of infant safety in a child care setting

ChildCare Education Institute is committed to developing relevant and up-to-date online coursework that enriches early childhood professionals and the care provided to children in child care settings. CCEI offers several courses that address the needs of infant safety in a child care setting.

3 Sep 2009

Humana renews contract agreement with Zix Corporation

Zix Corporation (ZixCorp(R)), (Nasdaq: ZIXI), the leader in email encryption services, today announced that Humana renewed its contract with ZixCorp. This latest agreement is a two-year extension of Humana's original agreement which has now spanned seven successful years.

3 Sep 2009

Will Obama disavow the pledge-breaking tax hikes that violate his campaign promise?

If Obama is serious about keeping his central campaign promise, will he disavow the four pledge-breaking provisions in the House Democrat healthcare bill?

3 Sep 2009

Biosante's CEO to present an overview of the company and its impending merger with Cell Genesys

BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that Stephen M. Simes, its president and CEO will present an overview of the company and its impending merger with Cell Genesys (NASDAQ: CEGE) at two healthcare investment and partnering conferences during the month of September.

3 Sep 2009

FDA extends review period for Endo Pharmaceuticals' testosterone undecanoate

Endo Pharmaceuticals announced today that it has been informed by the U.S. Food and Drug Administration (FDA) that the agency has extended its review period for its long-acting testosterone undecanoate injection for men diagnosed with hypogonadism, from Sept. 2, 2009 to Dec. 2, 2009.

3 Sep 2009

CORD I phase III clinical trial results of XIAFLEX published

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced that The New England Journal of Medicine (NEJM) has published in its September 3rd edition, the Company's pivotal CORD I Phase III clinical trial of XIAFLEX (collagenase clostridium histolyticum) a novel, first-in-class, biologic for the nonsurgical treatment of Dupuytren's contracture.

3 Sep 2009

Obama to address Congress on health reform

The Washington Post reports: "President Obama will address a joint session of Congress next Wednesday about the nation's health-care system, Democratic officials said Wednesday.

3 Sep 2009

Medical News

New Technology Showcase highlighting life science technologies to be featured

IsoFlow Infusion catheter allows physicians to increase drug concentrations at targeted sites

Tennessee Department Of Health to implement Upp's centralized emergency management solution

SDA survey participants questioned about their level of concern on H1N1 virus

Recurrence of Clostridium difficile infection is a growing area of concern in hospitals

ODAC calls for randomized study of Vion's Onrigin injection for treatment of the elderly AML patients

Nucletron announces financial results for the first half year of 2009

New probe for identifying chemical process affected proteins functions like GPS

Neuronetics raises funds to expand sales team for NeuroStar TMS Therapy

First swine-flu vaccine trials reveal strong immune response

Resident duty-hour reform increases medical complications in teaching hospitals

New Marketing Authorization Application for Rhucin submitted to the EMEA by Pharming

Biogen Idec's MS franchise to present at the 25th Congress of ECTRIMS

CCEI offers courses that address the needs of infant safety in a child care setting

Humana renews contract agreement with Zix Corporation

Will Obama disavow the pledge-breaking tax hikes that violate his campaign promise?

Biosante's CEO to present an overview of the company and its impending merger with Cell Genesys

FDA extends review period for Endo Pharmaceuticals' testosterone undecanoate

CORD I phase III clinical trial results of XIAFLEX published

Obama to address Congress on health reform

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News